Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
6 May 2024
m 14:42 | Diffuse large B-cell lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" |
m 14:42 | Follicular lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" |
m 14:42 | Mantle cell lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" |
m 14:42 | HIV-associated lymphoma diffhist +5 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480" |
|
14:40 | Acute myeloid leukemia 3 changes history +2,581 [Warner-admin; Jwarner (2×)] | |||
m |
|
14:40 (cur | prev) +8 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1411" | |||
m |
|
12:35 (cur | prev) +18 Jwarner talk contribs →Chemotherapy | |||
|
12:32 (cur | prev) +2,555 Jwarner talk contribs →High-dose Cytarabine monotherapy (HiDAC) {{#subobject:1dddf5|Regimen=1}} |
m 14:40 | Acute promyelocytic leukemia diffhist +8 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1411" |
5 May 2024
m 11:46 | Ewing sarcoma diffhist +602 Jwarner talk contribs →VACA {{#subobject:f92366|Regimen=1}} |
4 May 2024
m 00:32 | Breast cancer - historical diffhist +55 Jwarner talk contribs →Methotrexate & Thiotepa {{#subobject:c67a88|Regimen=1}} |
3 May 2024
|
m 20:27 | Classical Hodgkin lymphoma 2 changes history -1,252 [Jwarner (2×)] | |||
m |
|
20:27 (cur | prev) -1,368 Jwarner talk contribs →VEBEP {{#subobject:d7a2a6|Regimen=1}} | |||
m |
|
20:21 (cur | prev) +116 Jwarner talk contribs →VEBEP {{#subobject:d7a2a6|Regimen=1}} |
m 17:00 | HIV-associated lymphoma diffhist -24 Jwarner talk contribs →CNS therapy, prophylaxis {{#subobject:724xbj|Variant=1}} |
1 May 2024
m 20:14 | Ovarian cancer diffhist +3 Jwarner talk contribs →Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab {{#subobject:a38gbb|Regimen=1}} |
30 April 2024
m 22:54 | Follicular lymphoma diffhist +751 Jwarner talk contribs →References |